Repeating the analysis to only include first samples, showed again increased levels of CXCL9 and CCL20 in severe disease, but also increased levels of CXCL10 and a downregulation of CCL17 in patients with severe COVID-19 (Figure 3D). Here, CCL17 is linked to COVID-19.